EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Clinical Decision Support Tool to Promote Adoption of New Neonatal Hyperbilirubinemia Guidelines

Lucia An, Paul J Lukac iD, Deepa Kulkarni

Applied Clinical Informatics · 01.08.2024 · 15 (04) · 751-755

DOI: 10.1055/a-2348-3958 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Applied Clinical Informatics, erschienen am 01.08.2024. Verfasst von Lucia An und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics at UCLA Mattel Children's Hospital, Los Angeles, California, United States. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Hyperbilirubinemia, Neonatal, Practice Guidelines as Topic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to increase the adoption of revised newborn hyperbilirubinemia guidelines by building a clinical decision support (CDS) tool into templated notes.

Methods

We created a rule-based CDS tool that correctly populates the phototherapy threshold from more than 2,700 possible values directly into the note and guides clinicians to an appropriate follow-up plan consistent with the new recommendations. We manually reviewed notes before and after CDS tool implementation to evaluate new guidelines adherence, and surveys were used to assess clinicians' perceptions.

Results

Postintervention documentation showed a decrease in old risk stratification methods (48 to 0.4%, p < 0.01) and an increase in new phototherapy threshold usage (39 to 95%, p < 0.01) and inclusion of follow-up guidance (28 to 79%, p < 0.01). Survey responses on workflow efficiency and satisfaction did not significantly change after CDS tool implementation.

Conclusion

Our study details an innovative CDS tool that contributed to increased adoption of newly revised guidelines after the addition of this tool to templated notes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support Systems, ClinicalHyperbilirubinemia, NeonatalPractice Guidelines as TopicHumansInfant, NewbornGuideline Adherence

Autor:innen und Institutionen

  • Department of Pediatrics at UCLA Mattel Children's Hospital, Los Angeles, California, United States.
  • Department of Pediatrics and Office of Health Informatics and Analytics, University of California, Los Angeles, California, United States.

ORCID-Profile: Paul J Lukac

Förderung

  • NCATS NIH HHS

Zitieren

APA

An, L., Lukac, P. J., & Kulkarni, D. (2024). Clinical Decision Support Tool to Promote Adoption of New Neonatal Hyperbilirubinemia Guidelines. Applied Clinical Informatics, 15(04), 751-755. https://doi.org/10.1055/a-2348-3958

Vancouver

An L, Lukac PJ, Kulkarni D. Clinical Decision Support Tool to Promote Adoption of New Neonatal Hyperbilirubinemia Guidelines. Applied Clinical Informatics. 2024;15(04):751-755. doi:10.1055/a-2348-3958

BibTeX
@article{An2024,
  author = {An, Lucia and Lukac, Paul J and Kulkarni, Deepa},
  title = {Clinical Decision Support Tool to Promote Adoption of New Neonatal Hyperbilirubinemia Guidelines},
  journal = {Applied Clinical Informatics},
  year = {2024},
  volume = {15},
  number = {04},
  pages = {751--755},
  doi = {10.1055/a-2348-3958}
}
Kostenlos starten →